India's Dr. Lal PathLabs slips after CEO resigns
04/03/2024 08:13
** Shares of Dr. Lal PathLabs DLPA.NS fall 1.7% to 2,294.1
rupees
** Co said Bharath U resigns as chief executive officer
** CEO added that he will take up external assignment post
resignation
** Seventeen analysts covering the stock on avg have a
"Sell" rating; median PT is 2,452.5 rupees - LSEG data
** DLPA trading below its 50-day, 100-day and 200-day simple
moving averages since Feb.
** Stock down ~11% so far this quarter; set to snap three
consecutive quarterly gains if trend holds
(Reporting by Ashna Teresa Britto in Bengaluru)
((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise